20/20 Biolabs, Inc.
AIDX· Nasdaq
20/20 Biolabs, Inc.
- Last sale
- Oct 7, 2026 · -0.14%
- Market cap
- $4.43M
- 12.77M shares
- Filings
- 165
Price
Oct 7, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $2,045,133 | reported | |
| FY 2024 | 2024-12-31 | $1,752,343 | reported |
20/20 Biolabs, Inc. · CIK 1139685 · Engraved from SEC EDGAR
